Are you Dr. Monath?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 50 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
21 Finn Rd
Harvard, MA 01451Phone+1 978-456-3645- Is this information wrong?
Summary
- Dr. Thomas Monath, MD is an infectious disease specialist in Harvard, Massachusetts. He is currently licensed to practice medicine in Massachusetts.
Education & Training
- Brigham and Women's HospitalResidency, Internal Medicine, 1973 - 1974
- Brigham and Women's HospitalResidency, Internal Medicine, 1966 - 1968
- Harvard Medical SchoolClass of 1966
Certifications & Licensure
- MA State Medical License 1992 - 2016
Publications & Presentations
PubMed
- 26 citationsImmunogenicity and safety of fractional doses of yellow fever vaccines: a randomised, double-blind, non-inferiority trialAitana Juan-Giner, Derick Kimathi, Kyra H. Grantz, Mainga Hamaluba, Patrick Kazooba, Patricia Njuguna, Gamou Fall, Moussa Dia, Ndeye Sakha Bob, Thomas P. Monath, Alan ...> ;Lancet. 2021 Jan 9
- 73 citationsThe Origin of COVID-19 and Why It Matters.David M. Morens, Joel G. Breman, Charles H. Calisher, Peter C. Doherty, Beatrice H. Hahn, Gerald T. Keusch, Laura D. Kramer, James W. LeDuc, Thomas P. Monath, Jeffery ...> ;The American Journal of Tropical Medicine and Hygiene. 2020 Jul 22
- 9 citationsThe Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of nucleic acid (RNA and DNA) vaccines.Denny Kim, James S. Robertson, Jean-Louis Excler, Richard C. Condit, Patricia E. Fast, Marc Gurwith, George N. Pavlakis, Thomas P. Monath, Jonathan M. Smith, David Woo...> ;Vaccine. 2020 Jul 22
- Join now to see all
Press Mentions
- Fighting COVID-19 with the One Health InitiativeMarch 5th, 2021
- Zoonoses and Climate Change: Is One Health Enough?February 28th, 2021
- Consumptive Coagulopathy of Severe Yellow Fever Occurs Independently of Hepatocellular Tropism and Massive Hepatic InjuryDecember 2nd, 2020
- Join now to see all
Grant Support
- Live, Attenuated, Recombinant Vaccine - West NILE VirusNational Institute Of Allergy And Infectious Diseases2000–2002
- Chimeric Yellow Fever 17d/Dengue VaccinesNational Institute Of Allergy And Infectious Diseases2000
- Chimeric Yellow Fever 17d/Dengue And West NILE VaccinesNational Institute Of Allergy And Infectious Diseases2000
- Japanese Encephalitis Vaccine From Mutated CDNA CloneNational Institute Of Allergy And Infectious Diseases1996–1997
- Genetic Engineering Of Japanese Encephalitis VirusNational Institute Of Allergy And Infectious Diseases1994
- Novel Methods For Treatment And Postexposure ProphylaxisNational Institute Of Allergy And Infectious Diseases1993
- Monoclonal IGA For Prophylaxis Of Clostridium DifficileNational Institute Of Allergy And Infectious Diseases1993